NASDAQ:NVCR
NovoCure Limited Stock News
$16.47
+0.340 (+2.11%)
At Close: May 10, 2024
Strength Seen in NovoCure (NVCR): Can Its 8% Jump Turn into More Strength?
11:46am, Thursday, 23'rd Jun 2022 Zacks Investment Research
NovoCure (NVCR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the ro
Strength Seen in NovoCure (NVCR): Can Its 8% Jump Turn into More Strength?
09:16am, Thursday, 23'rd Jun 2022
NovoCure (NVCR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the ro
Why Novocure Stock Is Plunging This Week
08:25pm, Thursday, 16'th Jun 2022 The Motley Fool
The broader stock market sell-off is pulling Novocure down.
Why Novocure Stock Is Plunging This Week
04:25pm, Thursday, 16'th Jun 2022
The broader stock market sell-off is pulling Novocure down.
3 Stocks That Could Help You Retire a Millionaire
01:03pm, Monday, 13'th Jun 2022 The Motley Fool
All you need to reach a million dollars is some time, discipline, patience, and the right investments.
3 Stocks Down 50% or More That You Can Buy Right Now
10:05am, Saturday, 11'th Jun 2022 The Motley Fool
Huge rebounds could be in store for these beaten-down stocks.
3 Stocks Down 50% or More That You Can Buy Right Now
06:05am, Saturday, 11'th Jun 2022
Huge rebounds could be in store for these beaten-down stocks.
3 Stocks That Could Easily Turn $10,000 Into $50,000 by 2030
10:55am, Saturday, 28'th May 2022 The Motley Fool
A 5x return isn't a slam dunk with these stocks. But it's not a farfetched proposition.
3 Stocks That Could Easily Turn $10,000 Into $50,000 by 2030
06:55am, Saturday, 28'th May 2022
A 5x return isn't a slam dunk with these stocks. But it's not a farfetched proposition.
Benzinga's Top Ratings Upgrades, Downgrades For May 16, 2022
02:04pm, Monday, 16'th May 2022 Benzinga
Upgrades
Keefe, Bruyette & Woods upgraded the previous rating for Rocket Companies Inc (NYSE:RKT) from Underperform to Market Perform. Rocket Companies earned $0.15 in the first quarter, compared to $
Nasdaq Bear Market: 3 Great Stocks to Buy That Are Down 50% or More
09:55am, Wednesday, 11'th May 2022 The Motley Fool
Their long-term prospects look great -- even if their current stock charts don't.
Nasdaq Bear Market: 3 Great Stocks to Buy That Are Down 50% or More
05:55am, Wednesday, 11'th May 2022
Their long-term prospects look great -- even if their current stock charts don't.
NovoCure Can Recover On Its Long-Term Outlook
08:45am, Tuesday, 10'th May 2022
NovoCure's growth has stalled as their GBM market share has gone to 35%-40%, but GBM still offers several additional growth opportunities. Then there are the 4 P3 trials which, if successful, could ad
NovoCure: A Stalwart With More Upsides
06:38am, Monday, 09'th May 2022
Though there are many companies to choose from, I focus on leading innovators with either novel therapeutics or technologies. NovoCure is a premier developer of tumor treating fields that already enjo
3 Beaten-Down Stocks That Could Deliver 5X Gains By 2030
10:02am, Monday, 02'nd May 2022 The Motley Fool
These stocks are losers now. But they could be huge winners over the next few years.
